An EEG study of chronic post stroke aphasia patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202310887998176

Enrollment

Registered

2023-10-10

Start date

2023-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

Resting state EEG before and after recieving active sessions of tDCs

EEG resting state and western aphasia battery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age over 18 years. 2. Patients presenting with first ever ischemic stroke causing aphasia expressive or receptive or mixed 3. A duration of 3 months to 1 year from onset of stroke.

Exclusion criteria

Exclusion criteria: 1. Previous ischemic stroke or hemorrhagic stroke. 2. Contraindications to tDCS as: a history of epilepsy, intracranial surgeries, skull defects or pregnant females. 3. Scoring 14 or more out of 30 in Stroke Aphasia Depression Questionnaire 10.

Design outcomes

Primary

Measure	Time frame
1.tDCS can be used to treat chronic post stroke aphasia and causes changes in resting state EEG.	—

Secondary

Measure	Time frame
2. Explore the potential correlations between baseline resting state EEG in aphasic patients and structural brain lesions observed in MRI scans and baseline clinical skills.	—

Countries

Egypt

Contacts

Public ContactHussein Hammouda Hassan

Assisstant lecturer of Neurology Ain Shams university hospitals

Dochusseinsharaf@gmail.com01067035930

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026